|
1.
|
|
10 p, 859.5 KB |
Predicting AT(N) pathologies in Alzheimer's disease from blood-based proteomic data using neural networks
/
Zhang, Y. (University of Oxford) ;
Ghose, U. (University of Oxford) ;
Buckley, N.J. (University of Oxford) ;
Engelborghs, S. (Vrije Universiteit Brussel) ;
Sleegers, K. (University of Antwerp) ;
Frisoni, G.B. (Department of Psychiatry. University of Geneva) ;
Wallin, A. (University of Gothenburg) ;
Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ;
Popp, J. (University of Zürich) ;
Martinez-Lage, P. (CITA-Alzheimer Foundation) ;
Legido-Quigley, C. (Steno Diabetes Center) ;
Barkhof, F. (University College London) ;
Zetterberg, H. (Kong Kong Center for Neurodegenerative Diseases) ;
Visser, P.J. (VU University Medical Center) ;
Bertram, L. (University of Oslo) ;
Lovestone, S. (Janssen RD) ;
Nevado-Holgado, Alejo (University of Oxford) ;
Shi, L. (University of Oxford) ;
Universitat Autònoma de Barcelona
Background and objective: Blood-based biomarkers represent a promising approach to help identify early Alzheimer's disease (AD). Previous research has applied traditional machine learning (ML) to analyze plasma omics data and search for potential biomarkers, but the most modern ML methods based on deep learning has however been scarcely explored. [...]
2022 -  10.3389/fnagi.2022.1040001
Frontiers in aging neuroscience, Vol. 14 (29 2022) , p. 1040001
|
|
|
2.
|
|
12 p, 280.0 KB |
Alzheimer's disease research progress in the Mediterranean region : The Alzheimer's Association International Conference Satellite Symposium
/
Sexton, Claire (Alzheimer's Association (Illinois, Estats Units)) ;
Solis, Michele (Freelance science writer (Washington, Estats Units)) ;
Aharon-Peretz, Judith (Rappapaort School of Medicine (Haifa, Israel)) ;
Alexopoulos, Panagiotis (University of Patras (Grècia)) ;
Apostolova, Liana G. (Indiana University (Bloomington, Estats Units)) ;
Bayen, Eléonore (University of California San Francisco (California, Estats Units)) ;
Birkenhager, Betty (University Medical Center Groningen (Groningen, Països Baixos)) ;
Cappa, Stefano (IRCCS Mondino Foundation (Pavia, Itàlia)) ;
Constantinidou, Fofi (University of Cyprus (Nicosia, Xipre)) ;
Fortea, Juan (Institut d'Investigació Biomèdica Sant Pau) ;
Gerritsen, Debby L. (Radboud Medical Center Nijmegen (Nijmegen, Països Baixos)) ;
Hassanin, Hany I. (Ain Shams University (El Caire, Egipte)) ;
Ibáñez, Agustín (Universidad de San Andres & National Scientific and Technical Research Council (CONICET) (Buenos Aires, Argentina)) ;
Ioannidis, Panagiotis (Aristotle University of Thessaloniki (Thessaloniki, Grècia)) ;
Karageorgiou, Elissaios (Neurological Institute of Athens (Atenes, Grècia)) ;
Korczyn, Amos (Tel Aviv University (Tel Aviv, Israel)) ;
Leroi, Iracema (Trinity College Dublin (Dublín, Irlanda)) ;
Lichtwarck, Bjorn (Innlandet Hospital Trust (Ottestad, Noruega)) ;
Logroscino, Giancarlo (University Aldo Moro Bari (Bari, Itàlia)) ;
Lynch, Chris (Alzheimer's Disease International (Londres, Regne Unit))) ;
Mecocci, Patrizia (University of Perugia (Perugia, Itàlia)) ;
Molinuevo, José Luis (Barcelonaβeta Brain Research Center (BBRC)) ;
Papatriantafyllou, John (Ana Aslan International Foundation) ;
Papegeorgiou, Sokratis (National and Kapodistrian University of Athens (Atenes, Grècia)) ;
Politis, Antonis (National and Kapodistrian University of Athens (Atenes, Grècia)) ;
Raman, Rema (University of Southern California (California, Estats Units)) ;
Ritchie, Karen (Institut National de la Santé et de la Recherche Médicale (França)) ;
Sanchez-Juan, Pascual (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ;
Sano, Mary (The Mount Sinai Hospital (New York, Estats Units)) ;
Scarmeas, Nikolas (Columbia University (New York, Estats Units)) ;
Spiru, Luiza (Ana Aslan International Foundation) ;
Stathi, Afroditi (University of Birmingham (Regne Unit)) ;
Tsolaki, Magda (Aristotle University of Thessaloniki (Macedonia, Grècia)) ;
Yener, Gorsev (Izmir University of Economics (Izmir, Turquia)) ;
Zaganas, Ioannis (University of Crete (Creta, Grècia)) ;
Zygouris, Stelios (Centre for Research and Technology Hellas/ Information Technologies Institute (Thessaloniki, Grècia)) ;
Carrillo, Maria (Alzheimer's Association (Illinois, Estats Units)) ;
Universitat Autònoma de Barcelona
As research and services in the Mediterranean region continue to increase, so do opportunities for global collaboration. To support such collaborations, the Alzheimer's Association was due to hold its seventh Alzheimer's Association International Conference Satellite Symposium in Athens, Greece in 2021. [...]
2022 - 10.1002/alz.12588
Alzheimer's & Dementia, Vol. 18 Núm. 10 (october 2022) , p. 1957-1968
|
|
|
3.
|
|
13 p, 1.9 MB |
Genetic characterization of the ALFA study : Uncovering genetic profiles in the Alzheimer's continuum
/
Vilor-Tejedor, Natalia (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Genius, Patricia (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Rodríguez-Fernández, Blanca (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Minguillón, Carolina (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Sadeghi, Iman (Centre de Regulació Genòmica) ;
González-Escalante, Armand (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Crous-Bou, Marta (Hospital Universitari de Bellvitge) ;
Suárez-Calvet, Marc (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Grau-Rivera, Oriol (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Brugulat-Serrat, Anna (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Sánchez-Benavides, Gonzalo (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Esteller, M (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Fauria, Karine (Pasqual Maragall Foundation) ;
Molinuevo, José Luis (Pasqual Maragall Foundation) ;
Navarro, Arcadi 1969- (Universitat Pompeu Fabra) ;
Gispert, Juan Domingo (Institut Hospital del Mar d'Investigacions Mèdiques)
INTRODUCTION: In 2013, the ALzheimer's and FAmilies (ALFA) project was established to investigate pathophysiological changes in preclinical Alzheimer's disease (AD), and to foster research on early detection and preventive interventions. [...]
2023 - 10.1002/alz.13537
Alzheimer's & Dementia, 2023
|
|
|
4.
|
|
5 p, 415.5 KB |
The geography of the alzheimer's disease mortality in spain : Should we focus on industrial pollutants prevention?
/
Martínez-Solanas, Èrica (ISGlobal) ;
Vergara-Duarte, Montse (Universitat Pompeu Fabra) ;
Cerdà, Miquel Ortega (ENT Foundation) ;
Martín-Sánchez, Juan Carlos (Universitat Internacional de Catalunya) ;
Buxó, Maria (Institut d'Investigació Biomèdica de Girona) ;
Rodríguez-Farré, Eduard (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Benach, Joan (Universidad Autónoma de Madrid) ;
Pérez Albarracín, Glòria (Agència de Salut Pública de Barcelona) ;
Universitat Autònoma de Barcelona
Alzheimer's disease (AD) has a high worldwide prevalence but little is known about its aetiology and risk factors. Recent research suggests environmental factors might increase AD risk. We aim to describe the association between AD mortality and the presence of highly polluting industry in small areas in Spain between 1999 and 2010. [...]
2017 - 10.3390/healthcare5040089
Healthcare, Vol. 5 Núm. 4 (december 2017) , p. 89
|
|
|
5.
|
|
7 p, 1.2 MB |
C-Terminal fragments of the amyloid precursor protein in cerebrospinal fluid as potential biomarkers for Alzheimer disease
/
García-Ayllón, María-Salud (Hospital General Universitario de Elche) ;
Lopez-Font, Inmaculada (Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas) ;
Boix, Claudia P. (Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas) ;
Fortea, Juan (Fundació Catalana Síndrome de Down) ;
Sánchez-Valle, Raquel (Hospital Clínic i Provincial de Barcelona) ;
Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ;
Molinuevo, José Luis (Hospital Clínic i Provincial de Barcelona) ;
Zetterberg, Henrik (University College London) ;
Blennow, Kaj (University of Gothenburg) ;
Sáez-Valero, Javier (Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas) ;
Universitat Autònoma de Barcelona
This study assesses whether C-Terminal fragments (CTF) of the amyloid precursor protein (APP) are present in cerebrospinal fluid (CSF) and their potential as biomarkers for Alzheimer's disease (AD). Immunoprecipitation and simultaneous assay by Western blotting using multiplex fluorescence imaging with specific antibodies against particular domains served to characterize CTFs of APP in human CSF. [...]
2017 - 10.1038/s41598-017-02841-7
Scientific reports, Vol. 7 Núm. 1 (january 2017) , p. 2477
|
|
|
6.
|
|
|
7.
|
|
26 p, 4.4 MB |
Preclinical Evaluation of an Imidazole-Linked Heterocycle for Alzheimer's Disease
/
Bagán, Andrea (Universitat de Barcelona) ;
Rodriguez-Arévalo, Sergio (Universitat de Barcelona) ;
Taboada-Jara, Teresa (Universitat de Barcelona) ;
Griñán-Ferré, Christian (Universitat de Barcelona) ;
Pallàs, Mercè (Universitat de Barcelona) ;
Brocos Mosquera, Iria (Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Madrid) ;
Callado, Luis F. (Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Madrid) ;
Morales-García, José A. (Universidad Complutense de Madrid) ;
Pérez, Belén (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ;
Diaz, Caridad (Fundación MEDINA Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía) ;
Fernández-Godino, Rosario (Fundación MEDINA Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía) ;
Genilloud, Olga (Fundación MEDINA Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía) ;
Beljkas, Milan (University of Belgrade, Serbia) ;
Oljacic, Slavica (University of Belgrade, Serbia) ;
Nikolic, Katarina (University of Belgrade, Serbia) ;
Escolano, Carmen (Universitat de Barcelona)
Humanity is facing a vast prevalence of neurodegenerative diseases, with Alzheimer's disease (AD) being the most dominant, without efficacious drugs, and with only a few therapeutic targets identified. [...]
2023 - 10.3390/pharmaceutics15102381
Pharmaceutics, Vol. 15 Núm. 10 (2023) , p. 2381
|
|
|
8.
|
|
8 p, 1.9 MB |
Obesity and Alzheimer's disease, does the obesity paradox really exist? A magnetic resonance imaging study
/
Pegueroles, Jordi (Institut d'Investigació Biomèdica Sant Pau) ;
Jiménez, Amanda (Hospital Clínic i Provincial de Barcelona) ;
Vilaplana, Eduard (Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas) ;
Montal, Victor (Institut d'Investigació Biomèdica Sant Pau) ;
Carmona Iragui, María (Institut d'Investigació Biomèdica Sant Pau) ;
Pané, Adriana (Hospital Clínic i Provincial de Barcelona) ;
Alcolea, Daniel (Institut d'Investigació Biomèdica Sant Pau) ;
Videla Toro, Laura (Institut d'Investigació Biomèdica Sant Pau) ;
Casajoana, Anna (Hospital de Barcelona-SCIAS) ;
Clarimón, Jordi (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Ortega, Emilio (Hospital Clínic i Provincial de Barcelona) ;
Vidal, Josep (Hospital Clínic i Provincial de Barcelona) ;
Blesa, Rafael (Institut d'Investigació Biomèdica Sant Pau) ;
Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ;
Fortea, Juan (Institut d'Investigació Biomèdica Sant Pau) ;
Universitat Autònoma de Barcelona
Mid-life obesity is an established risk factor for Alzheimer's disease (AD) dementia,whereas late-life obesity has been proposed as a protective state. Weight loss, whichpredates cognitive decline, might explain this obesity paradox on AD risk. [...]
2018 - 10.18632/oncotarget.26162
Oncotarget, Vol. 9 Núm. 78 (january 2018) , p. 34691-34698
|
|
|
9.
|
|
135 p, 1.9 MB |
Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias : An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry
/
Lewczuk, Piotr (University Hospital of Białystok) ;
Riederer, Peter (University Hospital Würzburg) ;
O'Bryant, Sid E. (University of North Texas Health Science Center) ;
Verbeek, Marcel M. (Radboud Alzheimer center) ;
Dubois, Bruno (Salpêtrièrie Hospital) ;
Visser, Pieter Jelle (Vrije Universiteit Amsterdam) ;
Jellinger, Kurt A. (Institute of Clinical Neurobiology) ;
Engelborghs, Sebastiaan (University Hospital Antwerp (Bèlgica)) ;
Ramirez, Alfredo (University of Cologne) ;
Parnetti, Lucilla (University of Perugia) ;
Jack Jr, Clifford R. (Mayo Clinic) ;
Teunissen, Charlotte E. (VU University Medical Center Amsterdam) ;
Hampel, Harald (heimer (IM2A). Hôpital Pitié-Salpêtrière) ;
Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ;
Jessen, Frank (German Center for Neurodegenerative Disorders (DZNE)) ;
Glodzik, Lidia (NYU Langone Medical Center) ;
de Leon, Mony J. (NYU Langone Medical Center) ;
Fagan, Anne M. (Washington University School of Medicine) ;
Molinuevo, José Luis (Hospital Clínic i Provincial de Barcelona) ;
Jansen, Willemijn J. (Maastricht University) ;
Winblad, Bengt (Karolinska Institutet (Estocolm, Suècia)) ;
Shaw, Leslie M. (University of Pennsylvania) ;
Andreasson, Ulf (The Sahlgrenska Academy at the University of Gothenburg) ;
Otto, Markus (University of Ulm) ;
Mollenhauer, Brit (Kassel and University Medical Center Göttingen) ;
Wiltfang, Jens (University of Aveiro) ;
Turner, Martin R. (University of Oxford) ;
Zerr, Inga (German Center for Neurodegenerative Diseases) ;
Handels, Ron (Karolinska Institutet (Estocolm, Suècia)) ;
Thompson, Alexander G. (University of Oxford) ;
Johansson, Gunilla (Karolinska Institutet (Estocolm, Suècia)) ;
Ermann, Natalia (Universitätsklinikum Erlangen. and Friedrich-Alexander Universität Erlangen-Nürnberg) ;
Trojanowski, John Q. (University of Pennsylvania) ;
Karaca, Ilker (University of Bonn) ;
Wagner, Holger (University of Bonn) ;
Oeckl, Patrick (University of Ulm) ;
van Waalwijk van Doorn, Linda (Radboud Alzheimer center) ;
Bjerke, Maria (University of Antwerp) ;
Kapogiannis, Dimitrios (National Institute on Aging/National Institutes of Health (NIA/NIH)) ;
Kuiperij, H.Bea (Radboud Alzheimer center) ;
Farotti, Lucia (University of Perugia) ;
Li, Yi (NYU Langone Medical Center) ;
Gordon, Brian A. (Washington University School of Medicine) ;
Epelbaum, Stéphane (Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A)) ;
Vos, Stephanie J.B. (Maastricht University) ;
Klijn, Catharina J.M. (Radboud Alzheimer Center) ;
Van Nostrand, William E. (Stony Brook University) ;
Minguillon, Carolina (Fundació Pasqual Maragall) ;
Schmitz, Matthias (University Medical School) ;
Gallo, Carla (Universidad Peruana Cayetano Heredia) ;
Lopez Mato, Andrea (Maimonides University) ;
Thibaut, Florence (University Hospital Cochin-Site Tarnier 89 rue d'Assas) ;
Lista, Simone (heimer (IM2A). Hôpital Pitié-Salpêtrière) ;
Alcolea, Daniel (Institut d'Investigació Biomèdica Sant Pau) ;
Zetterberg, Henrik (UCL Institute of Neurology (Regne Unit)) ;
Blennow, Kaj (Sahlgrenska University Hospital (Suècia)) ;
Kornhuber, Johannes (Universitätsklinikum Erlangen) ;
Universitat Autònoma de Barcelona
In the 12 years since the publication of the first Consensus Paper of the WFSBP on biomarkers of neurodegenerative dementias, enormous advancement has taken place in the field, and the Task Force takes now the opportunity to extend and update the original paper. [...]
2018 - 10.1080/15622975.2017.1375556
World Journal of Biological Psychiatry, Vol. 19 Núm. 4 (19 2018) , p. 244-328
|
|
|
10.
|
|
7 p, 663.7 KB |
Common and rare TBK1 variants in early-onset Alzheimer disease in a European cohort
/
Verheijen, Jan (University of Antwerp) ;
van der Zee, Julie (University of Antwerp) ;
Gijselinck, Ilse (University of Antwerp) ;
Van den Bossche, Tobi (University Hospital Antwerp (Bèlgica)) ;
Dillen, Lubina (University of Antwerp) ;
Heeman, Bavo (University of Antwerp) ;
Gómez-Tortosa, Estrella (Hospital Universitario Fundación Jiménez Díaz) ;
Lladó, Albert (Hospital Clínic i Provincial de Barcelona) ;
Sanchez-Valle, Raquel (Hospital Clínic i Provincial de Barcelona) ;
Graff, Caroline (Karolinska University Hospital and Karolinska Institutet (Suecia)) ;
Pastor, Pau (Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas) ;
Pastor, Maria A. (Clínica Universidad de Navarra) ;
Benussi, Luisa (Istituto Centro San Giovanni di Dio-Fatebenefratelli) ;
Ghidoni, Roberta (Istituto Centro San Giovanni di Dio-Fatebenefratelli) ;
Binetti, Giuliano (Istituto Centro San Giovanni di Dio-Fatebenefratelli) ;
Clarimón, Jordi (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
de Mendonça, Alexandre (University of Lisbon) ;
Gelpi, Ellen (Hospital Clínic i Provincial de Barcelona) ;
Tsolaki, Magda (Aristotle University of Thessaloniki) ;
Diehl-Schmid, Janine (Technische Universität München) ;
Nacmias, Benedetta (University of Florence) ;
Almeida, Maria Rosário (University of Coimbra) ;
Borroni, Barbara (University of Brescia) ;
Matej, Radoslav (Thomayer Hospital in Prague) ;
Ruiz, Agustín (Fundació ACE) ;
Engelborghs, Sebastiaan (University Hospital Antwerp (Bèlgica)) ;
Vandenberghe, Rik (University Hospitals Leuven (Bèlgica)) ;
De Deyn, Peter P. (University Hospital Antwerp (Bèlgica)) ;
Cruts, Marc (University of Antwerp) ;
Van Broeckhoven, Christine (University of Antwerp) ;
Sleegers, Kristel (University of Antwerp) ;
Goeman, Johan ;
Nuytten, Dirk ;
Vandenbulcke, Mathieu ;
Santens, Patrick 700 1_ ;
Sieben, Anne ;
Dermaut, Bart ;
Versijpt, Jan ;
Michotte, Alex ;
Deryck, Olivier ;
Bergmans, Bruno ;
Willems, Christiana ;
Ivanoiu, Adrian ;
Salmon, Eric ;
Alexopoulos, Panagiotis (Technische Universität München) ;
Sorbi, Sandro ;
Bessi, Valentina ;
Bagnoli, Silvia ;
Santana, Isabel ;
Simões do Couto, Frederico ;
Martins, Madalena ;
Thonberg, Häkan ;
Fratiglioni, Laura ;
Padovani, Alessandro ;
Rohan, Zdenek ;
Razquin, Cristina ;
Lorenzo, Elena ;
Iglesias, Elena ;
Seijo-Martínez, Manuel ;
Rene, Ramon ;
Gascon, Jordi ;
Campdelacreu, Jaume ;
Koutroumani, Maria ;
Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ;
Fortea, Juan (Institut d'Investigació Biomèdica Sant Pau) ;
Blesa, Rafael (Institut d'Investigació Biomèdica Sant Pau) ;
Universitat Autònoma de Barcelona
TANK-binding kinase 1 (TBK1) loss-of-function (LoF) mutations are known to cause frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS), often combined with memory deficits early in the disease course. [...]
2018 - 10.1016/j.neurobiolaging.2017.10.012
Neurobiology of Aging, Vol. 62 (february 2018) , p. 245.e1-245.e7
|
|
visitant ::
identificació
alerta personal via correu electrònic o subscribiu-vos al 
canal RSS.
